News Releases

May 14, 2015

PHILADELPHIA, PA – Researchers from RTI Health Solutions (RTI-HS), a business unit of RTI International, will discuss the evolving landscape of health economics and outcomes research at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual International Meeting in...

April 28, 2015

Why the focus on real-world data in pharmaceutical, biotech, and medical device research?

According to Sean D. Candrilli, PhD, a Head of Health Economics at RTI-HS, it’s because companies seek to address a wide-range of non-interventional research questions—in addition to clinical trials—...

April 14, 2015

To mark their 20-year anniversary, the European Medicines Agency (EMA) published a book to capture changes and progress in medicine regulatory science over the past 20 years, and to describe how EMA has addressed important challenges for public and animal health.

April 7, 2015

A study featured in the 2014 Annual Report for RTI International, parent company to RTI Health Solutions, found that nalmefene combined with psychosocial support is cost-effective for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels.

April 6, 2015

April is National Irritable Bowel Syndrome (IBS) Awareness month. We’re proud to contribute to research to widen understanding and improve the lives of the as many as 1 in 5 people in the US living with IBS. Our experience consists of 25+ researchers with expertise in gastroenterology, including...

March 4, 2015

March is National Kidney Month, and RTI-HS joins patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for kidney health.

February 25, 2015

Elizabeth Andrews, Ph.D., Vice President, Pharmacoepidemiology and Risk Management at RTI Health Solutions has agreed to serve a second term as an academia/research institute representative and vice chair of the Reagan-Udall Foundation, Innovation in Medical Evidence Development and Surveillance...

February 25, 2015

RESEARCH TRIANGLE PARK, NC— To address the growing challenges of creating adequate security regulations to protect against terrorism, a new book, "Benefit-Cost Analyses for Security Policies," offers an outline for evaluating homeland security policies within the framework of benefit-cost...

February 24, 2015

RTI-HS researcher Emily Reese, PhD, MPH, was invited to speak about budget impact models (BIM) to the University of North Carolina at Chapel Hill ISPOR student chapter. Dr. Reese was the 2012-13 ISPOR Student Network Chair, responsible for providing oversight to ISPOR’s 60 student chapters...

February 17, 2015

The journal for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has released its latest collection of research articles delivering insights on economic evaluation and outcomes research, and conceptual, methodological, and health policy pieces. Our Health Preference...

January 29, 2015

RESEARCH TRIANGLE PARK, NC—RTI Health Solutions (RTI-HS), a business unit of RTI International, partnered with the U.S. Food and Drug Administration (FDA) to conduct a study on patients’ preferences which contributed to the Agency’s regulatory decision to approve the Maestro Rechargeable System...

January 26, 2015

Will FDA's patient-centered drug development initiatives increase the prevalence of patient-reported outcomes (PRO) research during early phases of drug development?

January 23, 2015

FDA wants to see patient perspectives on the benefits and risks of a new device when manufacturers seek market approval. But manufacturers don’t always know how to collect and use this data in the regulatory process.

January 20, 2015

Watch the recorded session of our webinar that explores the shift in payer perspectives in response to increased R&D efforts toward orphan products.

January 8, 2015

Jamie Rosenzweig, MD recently joined RTI-HS as Senior Director of Clinical Consulting and our 13th physician on staff. In his role, Rosenzweig serves as an internal consultant for projects that require diabetes, endocrinology, or internal medicine expertise as well as a consultant for our...

January 5, 2015

RESEARCH TRIANGLE PARK, NC— Kati Copley-Merriman, vice president of Market Access and Outcomes Strategy at RTI Health Solutions (RTI-HS), a business unit of RTI International, has been named a member of the Value in Health Editorial Advisory Board. Value in Health, the official journal of the...

December 9, 2014

Dr. Kenneth Rothman, Distinguished Fellow and Vice President of Epidemiology Research, had the honor of giving the 160th Cutter Lecture on Preventive Medicine at the Harvard School of Public Health on December 3rd, 2014.


December 9, 2014

RESEARCH TRIANGLE PARK, N.C. – A new report by researchers at RTI Health Solutions (RTI-HS) and parent company RTI International, found that although healthcare databases have allowed for greater access to real world medical data, using databases to evaluate the safety of medical products is...

December 3, 2014

Over 45 of our scientists and consultants attended the 17th Annual ISPOR European Congress in Amsterdam; below are some of their insights from the conference.

November 14, 2014

RESEARCH TRIANGLE PARK, NC — James (Jamie) Rosenzweig, MD, has joined RTI Health Solutions (RTI-HS), a business unit of RTI International, as senior director of clinical consulting.

October 29, 2014

AMSTERDAM— Researchers from RTI Health Solutions (RTI-HS), a business unit of RTI International, will discuss challenges and solutions for improving European health care at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress in Amsterdam,...

October 17, 2014

Together with colleagues from the University of Glasgow and Biogen Idec, Sorrel Wolowacz, Head of European Health Economics, and Lynda Doward, European Head of Patient-Reported Outcomes, co-authored an...

October 15, 2014

In late September, 2014, the FDA convened a public meeting entitled “Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease and other Heritable Bleeding Disorders." Dr.

August 1, 2014

On July 16, 2014, the Engelberg Center for Health Care Reform, in cooperation with the FDA, held an expert workshop that focused on the major issues related to the development and use of Patient-Reported Outcome (PRO) instruments to support...

July 31, 2014

When you choose a pharmaceutical research partner, you want to know the credentials of the team conducting your research and the relevant experience they bring to your project.